Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis

Atopic Dermatitis Clinical Trial

Official title:

Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis: a Single-center Prospective Observational Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05833880
• Other study ID #: 2023-A00605-40
• Status: Completed
• Start date: May 10, 2023
• Est. completion date: August 3, 2023

Study information

• Verified date: November 2023
• Source: Central Hospital, Nancy, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Complementary and alternative medicine are increasingly used all around the world and more specifically in chronic diseases such as atopic dermatitis. Sociodemographic and disease determinants associated with their use remain unclear. Moreover, most of studies involved children and little data are available for adults.

The main objective of this study is to identify factors associated with complementary and alternative medicine use in children and adults suffering from atopic dermatitis. The secondary objectives are to determine the prevalence of complementary and alternative medicine use, the main forms used and their modalities of use, patients' motivations for using these therapies and sources of information.

Patients of all ages consulting for their atopic dermatitis at the dermatology or pediatric allergology department of Nancy University Hospital over a 6 months period will be asked to fill out a questionnaire about their pathology and their use of complementary and alternative medicine. This questionnaire will be collected before they leave the hospital.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 89
• Est. completion date: August 3, 2023
• Est. primary completion date: August 3, 2023
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• All patients, adults or children, without age limit;

• Patients visiting the dermatology or pediatric allergology department of Nancy University Hospital;

• Patients with atopic dermatitis confirmed on clinical examination by the physician;

• Patients with a history of atopic dermatitis or newly diagnosed patients;

• Patient affiliated to a social security plan or beneficiary of such a plan;

• Patients who understand French and are able to complete a self-administered questionnaire or have the option of assistance in completing it.

Exclusion Criteria:

• Patient with at least one other dermatological pathology or non-atopic eczema (contact eczema, ...);

• Patient without a confirmed diagnosis of atopic dermatitis by a physician;

• Patient who has already completed the questionnaire during a previous consultation;

• Pregnant and breastfeeding women;

• Refusal of the patient or at least one of the parents for children;

• Patient placed under court protection, guardianship or curatorship;

• Patient deprived of liberty by a judicial or administrative decision.

Related Conditions & MeSH terms

• Atopic Dermatitis
• Dermatitis
• Dermatitis, Atopic
• Eczema

Intervention

Behavioral:
• Self-administered questionnaire
Self-administered questionnaire regarding complementary and alternative medicine use

Locations

Country	Name	City	State
France	University Hospital of Nancy	Nancy

Sponsors (1)

Lead Sponsor	Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Binary variable: use of complementary and alternative medicine (yes/no)	Binary variable: use of complementary and alternative medicine (yes/no), variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)
Secondary	Percentage of patients using complementary and alternative medicine in relation to the total number of patients included in the study	Percentage of patients using complementary and alternative medicine in relation to the total number of patients included in the study, variable collected by questionnaire according to the patient's declaration (use or not use of complementary and alternative medicine) and then calculated	Baseline (J0)
Secondary	Forms of complementary and alternative medicine used	Forms of complementary and alternative medicine used, variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)
Secondary	Modalities of use of complementary and alternative medicine	Modalities of use of complementary and alternative medicine, variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)
Secondary	Patients' motivations for using complementary and alternative medicine	Patients' motivations for using complementary and alternative medicine, variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)
Secondary	Sources of information regarding complementary and alternative medicine	Sources of information regarding complementary and alternative medicine, variable collected by questionnaire, as reported by the patient (or the patient's parents)	Baseline (J0)